PDL BioPharma Company Profile (NASDAQ:PDLI)

About PDL BioPharma

PDL BioPharma logoPDL BioPharma, Inc., formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various biotechnology and pharmaceutical companies, and royalty and other assets acquired. The Company provides non-dilutive growth capital and financing solutions to late-stage public and private healthcare companies and offers immediate financial monetization of royalty streams to companies, academic institutions and inventors. It evaluates its investments based on the quality of the income generating assets and potential returns on investment. It is focused on intellectual property asset management, acquiring income generating assets and maximizing value for its stockholders, among others. It receives royalties on sales of over ten humanized antibody products, which include Avastin, Herceptin, Xolair, Kadcyla, Tysabri, Actemra, Gazyva and Entyvio all of which are approved for use.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: PDLI
  • CUSIP: 69329Y10
Key Metrics:
  • Previous Close: $2.76
  • 50 Day Moving Average: $3.21
  • 200 Day Moving Average: $3.24
  • Trailing P/E Ratio: 1.96
  • Foreward P/E Ratio: 13.14
  • P/E Growth: 0.40
  • Market Cap: $456.89M
  • Outstanding Shares: 165,540,000
  • Beta: 0.72
Additional Links:
Companies Related to PDL BioPharma:

Analyst Ratings

Consensus Ratings for PDL BioPharma (NASDAQ:PDLI) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $3.75 (35.87% upside)

Analysts' Ratings History for PDL BioPharma (NASDAQ:PDLI)
Show:
DateFirmActionRatingPrice TargetDetails
8/7/2016Cowen and CompanyReiterated RatingHold$3.50View Rating Details
2/23/2016Royal Bank Of CanadaLower Price TargetSector Perform$5.00 -> $4.00View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for PDL BioPharma (NASDAQ:PDLI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/4/2016Q216$0.08$0.09$33.46 million$21.00 millionViewN/AView Earnings Details
5/4/2016Q116$0.50$0.52$142.05 million$103.10 millionViewN/AView Earnings Details
2/22/2016Q415$0.54$0.61$149.20 million$178.10 millionViewListenView Earnings Details
11/4/2015Q315$0.61$0.42$164.80 million$124.60 millionViewN/AView Earnings Details
8/5/2015Q215$0.52$0.47$137.75 million$138.10 millionViewN/AView Earnings Details
5/6/2015Q115$0.52$0.50$140.80 million$149.71 millionViewN/AView Earnings Details
2/23/2015Q414$0.57$0.32$158.15 million$117.10 millionViewListenView Earnings Details
11/10/2014Q314$0.56$0.61$165.10 million$164.60 millionViewN/AView Earnings Details
8/18/2014Q214$0.46$0.52$134.07 million$162.80 millionViewListenView Earnings Details
5/12/2014Q114$0.45$0.44$130.93 million$139.70 millionViewN/AView Earnings Details
3/3/2014Q413$0.43$0.39$115.22 million$110.10 millionViewN/AView Earnings Details
11/6/2013Q313$0.37$0.36$97.09 million$97.30 millionViewN/AView Earnings Details
8/8/2013Q2 2013$0.54$0.62$138.20 million$143.60 millionViewN/AView Earnings Details
5/9/2013Q1 2013$0.35$0.36$91.69 million$91.80 millionViewN/AView Earnings Details
3/1/2013Q4 2012$0.31$0.34$86.08 million$86.10 millionViewN/AView Earnings Details
11/5/2012Q312$0.33$0.32$85.03 million$85.20 millionViewN/AView Earnings Details
8/2/2012$0.44$0.52ViewN/AView Earnings Details
5/3/2012$0.27$0.29ViewN/AView Earnings Details
2/23/2012$0.28$0.24ViewN/AView Earnings Details
11/9/2011$0.27$0.28ViewN/AView Earnings Details
7/27/2011$0.39$0.39ViewN/AView Earnings Details
4/27/2011$0.24$0.25ViewN/AView Earnings Details
2/28/2011$0.21$0.20ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PDL BioPharma (NASDAQ:PDLI)
Current Year EPS Consensus Estimate: $0.51 EPS
Next Year EPS Consensus Estimate: $0.21 EPS

Dividends

Current Dividend Information for PDL BioPharma (NASDAQ:PDLI)
Annual Dividend:$0.20
Dividend Yield:7.25%
Payout Ratio:14.29% (Based on Trailing 12 Months of Earnings)
39.22% (Based on Current Year Consensus EPS Estimate)
95.24% (Based on Next Year Consensus EPS Estimate)

Dividend History for PDL BioPharma (NASDAQ:PDLI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/4/2016quarterly$0.056.25%6/2/20166/6/20166/13/2016
2/1/2016quarterly$0.057.27%3/2/20163/4/20163/11/2016
2/2/2015quarterly$0.158.22%9/2/20169/4/20169/11/2016
2/2/2015quarterly$0.158.22%6/1/20166/5/20166/12/2016
1/30/2015quarterly$0.158.23%6/3/20156/5/20156/12/2015
1/30/2015quarterly$0.158.23%3/3/20153/5/20153/12/2015
1/30/2015quarterly$0.158.23%12/2/201512/4/201512/11/2015
1/30/2015quarterly$0.158.23%9/2/20159/4/20159/11/2015
1/31/2014quarterly$0.156.59%9/3/20149/5/20149/12/2014
1/31/2014quarterly$0.156.59%3/3/20143/5/20143/12/2014
1/31/2014quarterly$0.156.59%12/3/201412/5/201412/12/2014
1/31/2014quarterly$0.156.59%6/3/20146/5/20146/12/2014
1/31/2013quarterly$0.158.72%12/3/201312/5/201312/12/2013
1/31/2013quarterly$0.158.72%6/3/20136/5/20136/12/2013
1/31/2013quarterly$0.158.72%9/3/20139/5/20139/12/2013
1/30/2013quarterly$0.158.72%3/1/20133/5/20133/12/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for PDL BioPharma (NASDAQ:PDLI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2016Peter S GarciaVPBuy10,000$3.00$30,000.00View SEC Filing  
12/15/2015Peter S. GarciaCFOBuy5,000$3.64$18,200.00View SEC Filing  
12/14/2015Peter S. GarciaCFOBuy10,000$3.42$34,200.00View SEC Filing  
12/7/2015Steffen PietzkeCAOBuy20,590$3.64$74,947.60View SEC Filing  
8/14/2015Peter S GarciaCFOBuy20,000$5.83$116,600.00View SEC Filing  
11/26/2014Harold E SelickDirectorBuy6,000$8.08$48,480.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PDL BioPharma (NASDAQ:PDLI)
DateHeadline
News IconDorfman: Cash flow can provide direction for investing in stock market (NASDAQ:PDLI)
triblive.com - August 23 at 11:11 AM
News IconOn Investments: One method for picking stocks – free cash flow (NASDAQ:PDLI)
www.omaha.com - August 23 at 11:11 AM
News IconPDL BioPharma, Inc.'s (PDLI): Stock under Review - Hot Stocks Point (NASDAQ:PDLI)
www.hotstockspoint.com - August 22 at 6:42 PM
capitalcube.com logoETF’s with exposure to PDL BioPharma, Inc. : August 22, 2016 (NASDAQ:PDLI)
www.capitalcube.com - August 22 at 6:42 PM
News IconSmall Cap Insight on Shares of PDL BioPharma, Inc. (NASDAQ:PDLI) - Duncan Research (NASDAQ:PDLI)
www.duncanindependent.com - August 20 at 6:24 PM
News IconNews review of 2 biotech stocks: PDL BioPharma, Inc. (NASDAQ:PDLI), Amicus Therapeutics, Inc. (NASDAQ:FOLD) - The Voice Registrar (NASDAQ:PDLI)
voiceregistrar.com - August 19 at 6:42 PM
investornewswire.com logoWill PDL BioPharma, Inc. (NASDAQ:PDLI) Hit $4 Price Target? - Investor Newswire (NASDAQ:PDLI)
www.investornewswire.com - August 15 at 7:07 PM
News IconTrading the Biotech News: PDL BioPharma, Inc. (NASDAQ:PDLI), Neuralstem, Inc. (NASDAQ:CUR) - The Voice Registrar (NASDAQ:PDLI)
voiceregistrar.com - August 15 at 7:07 PM
finance.yahoo.com logoPDL BIOPHARMA, INC. Financials (NASDAQ:PDLI)
finance.yahoo.com - August 12 at 6:55 PM
News IconBiotech Stocks Worth a Closer Look: PDL BioPharma, Inc. (NASDAQ:PDLI), Amgen Inc. (NASDAQ:AMGN) - The Voice Registrar (NASDAQ:PDLI)
voiceregistrar.com - August 11 at 7:16 PM
News IconInsider Trading and Share Price Activity: PDL BioPharma Inc (NASDAQ:PDLI) - Post Registrar (NASDAQ:PDLI)
postregistrar.com - August 11 at 7:16 PM
investing.com logoPDL BioPharma - Less Dividend Equals More Deals (NASDAQ:PDLI)
www.investing.com - August 11 at 10:01 AM
capitalcube.com logoPDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:PDLI)
www.capitalcube.com - August 10 at 7:13 PM
News IconHigh Volume Healthcare Stocks: PDL BioPharma, Inc. (NASDAQ:PDLI), Johnson & Johnson (NYSE:JNJ) - TWN (NASDAQ:PDLI)
thewellesleysnews.com - August 9 at 7:01 PM
streetupdates.com logoAnalysts Rating updates about two Stocks: Abbott Laboratories (NYSE:ABT) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates (NASDAQ:PDLI)
www.streetupdates.com - August 9 at 7:01 PM
fortune.com logoPDL BioPharma, Inc. (NASDAQ:PDLI) Insider Activities Are in the Air - Review Fortune (NASDAQ:PDLI)
reviewfortune.com - August 9 at 7:01 PM
News IconHealthcare Stocks Directions: PDL BioPharma, Inc. (NASDAQ:PDLI), Opko Health, Inc. (NASDAQ:OPK) - TWN (NASDAQ:PDLI)
thewellesleysnews.com - August 9 at 7:01 PM
capitalcube.com logoETF’s with exposure to PDL BioPharma, Inc. : August 9, 2016 (NASDAQ:PDLI)
www.capitalcube.com - August 9 at 7:01 PM
capitalcube.com logoPDL BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : PDLI-US : August 8, 2016 (NASDAQ:PDLI)
www.capitalcube.com - August 8 at 11:29 AM
thestreet.com logoPDL BioPharma (PDLI) Stock Plummets on Q2 Revenue Miss (NASDAQ:PDLI)
www.thestreet.com - August 5 at 6:59 PM
fool.com logoPDL BioPharma's Stock Crumbles on Dismal Second-Quarter Results (NASDAQ:PDLI)
www.fool.com - August 5 at 3:19 PM
finance.yahoo.com logoPDL BioPharma Announces Second Quarter 2016 Financial Results (NASDAQ:PDLI)
finance.yahoo.com - August 5 at 9:49 AM
finance.yahoo.com logoEdited Transcript of PDLI earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:PDLI)
finance.yahoo.com - August 5 at 9:49 AM
streetinsider.com logoPDL BioPharma (PDLI) Eliminates Qtr Dividend (NASDAQ:PDLI)
www.streetinsider.com - August 4 at 7:14 PM
twst.com logoPDL BioPharma Inc.: PDL BioPharma Announces Elimination of Quarterly Cash Dividend (NASDAQ:PDLI)
www.twst.com - August 4 at 7:14 PM
finance.yahoo.com logoPDL BioPharma Announces Elimination of Quarterly Cash Dividend (NASDAQ:PDLI)
finance.yahoo.com - August 4 at 7:14 PM
sg.finance.yahoo.com logoPDL BioPharma posts 2Q profit (NASDAQ:PDLI)
sg.finance.yahoo.com - August 4 at 7:14 PM
biz.yahoo.com logoQ2 2016 PDL BioPharma Inc Earnings Release - After Market Close (NASDAQ:PDLI)
biz.yahoo.com - August 4 at 9:55 AM
biz.yahoo.com logoPDL BIOPHARMA, INC. Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:PDLI)
biz.yahoo.com - August 3 at 10:01 AM
stocksdaily.net logoPDL BioPharma, Inc. (NASDAQ:PDLI) Cash Balance At $220.352 ... - Stocks Daily (NASDAQ:PDLI)
www.stocksdaily.net - July 29 at 9:48 AM
live-pr.com logo"PDL BioPharma, Inc. (PDLI) - Financial and Strategic SWOT Analysis Review" now available at Fast Market Research (NASDAQ:PDLI)
www.live-pr.com - July 28 at 7:00 PM
publicnow.com logoPDL BioPharma to Announce Second Quarter 2016 Financial Results on August 4, 2016 (NASDAQ:PDLI)
www.publicnow.com - July 28 at 7:18 AM
streetupdates.com logoNotable Analysts Assessment of Stocks: Amgen Inc. (NASDAQ:AMGN) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates (NASDAQ:PDLI)
www.streetupdates.com - July 27 at 7:08 PM
fortune.com logoLatest PDL BioPharma, Inc. (NASDAQ:PDLI) Target Price Suggests ... - Review Fortune (NASDAQ:PDLI)
reviewfortune.com - July 27 at 7:08 PM
stocksdaily.net logoCash And Short-Term Investments For PDL BioPharma, Inc. (NASDAQ:PDLI) Was $220.352 - Stocks Daily (NASDAQ:PDLI)
www.stocksdaily.net - July 22 at 6:38 PM
streetupdates.com logoNotable Buzzers: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates (NASDAQ:PDLI)
www.streetupdates.com - July 22 at 6:38 PM
fiscalstandard.com logoBroker Outlook For PDL BioPharma, Inc. (NASDAQ:PDLI) - Fiscal Standard (NASDAQ:PDLI)
www.fiscalstandard.com - July 21 at 9:39 AM
streetupdates.com logoAnalysts Actions to Track: Gilead Sciences, Inc. (NASDAQ:GILD) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates (NASDAQ:PDLI)
www.streetupdates.com - July 19 at 6:53 PM
News IconNews review of 2 biotech stocks: PDL BioPharma, Inc. (NASDAQ:PDLI), Regeneron Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:PDLI)
voiceregistrar.com - July 19 at 6:53 PM
News IconShares Lower on the Year PDL BioPharma, Inc. (NASDAQ:PDLI) - Press Telegraph (NASDAQ:PDLI)
presstelegraph.com - July 19 at 7:10 AM
investornewswire.com logoIs $4 Price Target Attainable For PDL BioPharma, Inc. (NASDAQ:PDLI)? - Investor Newswire (NASDAQ:PDLI)
www.investornewswire.com - July 19 at 7:10 AM
capitalcube.com logoPDL BioPharma, Inc. – Value Analysis (NASDAQ:PDLI) : July 18, 2016 (NASDAQ:PDLI)
www.capitalcube.com - July 18 at 4:09 PM
istreetwire.com logo3 Stocks in Focus: Corporate Office Properties Trust (OFC), PDL BioPharma, Inc. (PDLI), Cosi Inc. (COSI) - iStreetWire (NASDAQ:PDLI)
istreetwire.com - July 16 at 10:00 AM
news.cmlviz.com logoPDL BioPharma Inc Realized Volatility Hits Elevated Level - CML News (NASDAQ:PDLI)
news.cmlviz.com - July 15 at 11:51 AM
News IconHow Many PDL BioPharma Inc (NASDAQ:PDLI)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:PDLI)
www.consumereagle.com - July 13 at 7:06 PM
streetupdates.com logoNoticeable Analyst's ideas: UnitedHealth Group Incorporated (NYSE:UNH) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates (NASDAQ:PDLI)
www.streetupdates.com - July 13 at 9:43 AM
news.cmlviz.com logoOption Market: PDL BioPharma Inc Risk Hits An Inflection Point - CML News (NASDAQ:PDLI)
news.cmlviz.com - July 12 at 7:00 PM
investornewswire.com logoStrong Sell Calls For PDL BioPharma, Inc. (NASDAQ:PDLI) At 0 - Investor Newswire (NASDAQ:PDLI)
www.investornewswire.com - July 11 at 6:44 PM
capitalcube.com logoPDL BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : PDLI-US : July 11, 2016 (NASDAQ:PDLI)
www.capitalcube.com - July 11 at 8:25 AM
news.cmlviz.com logoPDL BioPharma, Inc. Stock Momentum Hits Weakness - CML News (NASDAQ:PDLI)
news.cmlviz.com - July 8 at 9:41 AM

Social

PDL BioPharma (NASDAQ:PDLI) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff